NARA Discovery
Article Details
← Back to Search Results
Journal Article

Biodegradable nanoparticles combining cancer cell targeting and anti-angiogenic activity for synergistic chemotherapy in epithelial cancer

Francesca Moret; Claudia Conte; Diletta Esposito; Giovanni Dal Poggetto; Concetta Avitabile; Francesca Ungaro; Natascia Tiso; Alessandra Romanelli; Paola Laurienzo; Elena Reddi; Fabiana Quaglia
Drug Delivery and Translational Research · Vol. 12, Issue 10 · pp. 2488-2500 · 2022

Abstract

A biodegradable engineered nanoplatform combining anti-angiogenic activity and targeting of cancer cells to improve the anticancer activity of docetaxel (DTX) is here proposed. Indeed, we have developed biodegradable nanoparticles (NPs) of poly(ethylene glycol)-poly(ε-caprolactone), exposing on the surface both folate motifs (Fol) for recognition in cells overexpressing Folate receptor-α (FRα) and the anti-angiogenic hexapeptide aFLT1. NPs showed a size around 100 nm, the exposure of 60% of Fol moieties on the surface, and the ability to entrap DTX and sustain its release with time. NPs were stable in simulated biological fluids and slightly interacted with Fetal Bovine serum, especially in the formulation decorated with Fol and aFLT1. The presence of Fol on NPs did not impair the anti-angiogenic activity of aFLT1, as assessed by in vitro tube formation assay in HUVEC endothelial cells. In both 2D and 3D KB cell cultures in vitro, the cytotoxicity of DTX loaded in NPs was not significantly affected by Fol/aFLT1 double decoration compared to free DTX. Remarkably, NPs distributed differently in 3D multicellular spheroids of FRα-positive KB cancer cells depending on the type of ligand displayed on the surface. In particular, NPs unmodified on the surface were randomly distributed in the spheroid, whereas the presence of Fol promoted the accumulation in the outer rims of the spheroid. Finally, NPs with Fol and aFLT1 gave a uniform distribution throughout the spheroid structure. When tested in zebrafish embryos xenografted with KB cells, NPs displaying Fol/aFLT1 reduced DTX systemic toxicity and inhibited the growth of the tumor mass and associated vasculature synergistically. Overall, nanotechnology offers excellent ground for combining therapeutic concepts in cancer, paving the way to novel multifunctional nanopharmaceuticals decorated with bioactive elements that can significantly improve therapeutic outcomes. Graphical abstract

Bibliographic Information

JournalDrug Delivery and Translational Research
PublisherSpringer
Publication Date2022-10-01
Publication Year2022
Volume12
Issue10
Pages2488-2500
Document TypeJournal Article
Print ISSN2190-393X
eISSN2190-3948
DOI10.1007/s13346-021-01090-6

Access Information

NARA Access Coverage2011-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13346
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.